These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15972663)

  • 1. Cellular FLIP long form augments caspase activity and death of T cells through heterodimerization with and activation of caspase-8.
    Dohrman A; Russell JQ; Cuenin S; Fortner K; Tschopp J; Budd RC
    J Immunol; 2005 Jul; 175(1):311-8. PubMed ID: 15972663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NF-kappa B activation.
    Dohrman A; Kataoka T; Cuenin S; Russell JQ; Tschopp J; Budd RC
    J Immunol; 2005 May; 174(9):5270-8. PubMed ID: 15843523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
    Davidson WF; Haudenschild C; Kwon J; Williams MS
    J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic overexpression of the Caspase-8 inhibitor FLIP(short) leads to impaired T cell proliferation and an increased memory T cell pool after staphylococcal enterotoxin B injection.
    Oehme I; Neumann F; Bösser S; Zörnig M
    Eur J Immunol; 2005 Apr; 35(4):1240-9. PubMed ID: 15761846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The caspase 8 inhibitor c-FLIP(L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes.
    Lens SM; Kataoka T; Fortner KA; Tinel A; Ferrero I; MacDonald RH; Hahne M; Beermann F; Attinger A; Orbea HA; Budd RC; Tschopp J
    Mol Cell Biol; 2002 Aug; 22(15):5419-33. PubMed ID: 12101236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex.
    Micheau O; Thome M; Schneider P; Holler N; Tschopp J; Nicholson DW; Briand C; Grütter MG
    J Biol Chem; 2002 Nov; 277(47):45162-71. PubMed ID: 12215447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
    Strauss G; Knape I; Melzner I; Debatin KM
    J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of TCR-induced CD8 T cell death by IL-12: regulation of Fas ligand and cellular FLIP expression and caspase activation by IL-12.
    Lee SW; Park Y; Yoo JK; Choi SY; Sung YC
    J Immunol; 2003 Mar; 170(5):2456-60. PubMed ID: 12594270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of caspases-8 and -10 by FLIP(L).
    Boatright KM; Deis C; Denault JB; Sutherlin DP; Salvesen GS
    Biochem J; 2004 Sep; 382(Pt 2):651-7. PubMed ID: 15209560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
    Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
    J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity.
    Kirchhoff S; Müller WW; Krueger A; Schmitz I; Krammer PH
    J Immunol; 2000 Dec; 165(11):6293-300. PubMed ID: 11086065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes.
    Gilot D; Serandour AL; Ilyin GP; Lagadic-Gossmann D; Loyer P; Corlu A; Coutant A; Baffet G; Peter ME; Fardel O; Guguen-Guillouzo C
    Carcinogenesis; 2005 Dec; 26(12):2086-94. PubMed ID: 16033771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of death receptor signals by cellular FLIP.
    Irmler M; Thome M; Hahne M; Schneider P; Hofmann K; Steiner V; Bodmer JL; Schröter M; Burns K; Mattmann C; Rimoldi D; French LE; Tschopp J
    Nature; 1997 Jul; 388(6638):190-5. PubMed ID: 9217161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
    Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S
    Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice.
    Arreaza G; Salojin K; Yang W; Zhang J; Gill B; Mi QS; Gao JX; Meagher C; Cameron M; Delovitch TL
    Clin Immunol; 2003 May; 107(2):103-15. PubMed ID: 12763479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation.
    Misra RS; Russell JQ; Koenig A; Hinshaw-Makepeace JA; Wen R; Wang D; Huo H; Littman DR; Ferch U; Ruland J; Thome M; Budd RC
    J Biol Chem; 2007 Jul; 282(27):19365-74. PubMed ID: 17462996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of death-receptor induced caspase-8-activation in the death-inducing signalling complex by uncoupling of oxidative phosphorylation.
    Vier J; Gerhard M; Wagner H; Häcker G
    Mol Immunol; 2004 Jan; 40(10):661-70. PubMed ID: 14644092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines.
    Shain KH; Landowski TH; Dalton WS
    J Immunol; 2002 Mar; 168(5):2544-53. PubMed ID: 11859150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector CD4+ T cells generate intermediate caspase activity and cleavage of caspase-8 substrates.
    Misra RS; Jelley-Gibbs DM; Russell JQ; Huston G; Swain SL; Budd RC
    J Immunol; 2005 Apr; 174(7):3999-4009. PubMed ID: 15778357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.